Teaching TY Haematinics
Transcript of Teaching TY Haematinics
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 1
HAEMATINICS
TY CS& SC IMU 2012ME 1/11 SEM 3 12/3-17/3/2012
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 2
HAEMATINICS
These are the substances which are required for the formation of blood (erythropoiesis) and are used for the treatment of anaemia.
These are mainly IRON, FOLIC ACID & VIT B12
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 3
Case Scenario
A 26 year old lady with 22 weeks of pregnancy attends the 1st 1ntenatal booking visit. On enquiry she has had 3 normal full term deliveries and one caesarean section for a twin pregnancy at 38 weeks of pregnancy and one abortion at 19 weeks. She feels easily tired too and sleepy – She is really tiring to look after the children nowadays –this is also during the last week.On Examination She is anaemic. She is otherwise fit and well. Hb level 10.5 gm/dlMicrocytic hypochromic (MCV <80 fL)Macrocytic (MCV >100 fL)Treatment- Haematinics
fL = femto-litre = 10−15 L = 1 μm3
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 4
TY CSU IMU
Normal blood film Severe iron deficiency anaemia
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 5
Red cells – Macrocytosis
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 6
TY CSU IMU
White cells - Hypersegmented neutrophils
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 7
7
Anaemia
• What is anaemia?– Haemoglobin level: The cut-off point for
the women by WHO 12 g/dl. Men 13 g/dl– Anaemia is a reduction in the number of
RBCs or the Haemoglobin content of blood below normal for age and sex of the individual
– Acute/ Chronic
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 8
34.3
33.6
32.1
NUTRITION DISEASE RELATED
UNEXPLAINED
ALL ANAEMIA CASES
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 9
48.3
17.2
18.8
IRON
FOLIC ACID
9.9
B12
5.8
FA & B12IRON FA & B12
ANAEMIA WITH NUTRI. DEFICIENCY
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 10
PATHOGENESIS
It is a condition in which the balance between production and destruction of RBCs is disturbed by:-
1. Blood Loss2. Impaired red cell formation3. Increased destruction of RBCs
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 11
11
Types (Blood Picture)
• Normocytic (MCV 80-100 fL)
• Microcytic hypochromic / normochromic (MCV <80 fL)
• Macrocytic (MCV >100 fL)
fL = femto-litre = 10−15 L = 1 μm3
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 12
12
Diagnosis
• Peripheral blood film
• Flow cytometry – automatic counters
fL = femto-litre = 10−15 L = 1 μm3
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 13
13
Erythropoiesis
• Iron
• Vitamin B12
• Folic acid
• It is regulated by erythropoietin
- secreted by kidneys
- stimulates the bone marrow
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 14
IRON
Distribution in the Body:Total body iron in an adult is 2.5-5g. It is more in men 50 mg/kg than in women 38 mg/kg.
It is distributed into:--Hemoglobin – 66%Iron stores as ferritin, Haemosiderin 25%Myoglobin - 3%Parenchymal Iron (in enzymes) – 6%
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 15
Daily Requirement :-
Adult male - 0.5 – 1 mgAdult Female - 1 – 2 mgInfants - 60 g / kg
Children - 25 g / kgPregnancy - 3 – 5 mg
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 16
Dietary SourcesDiet contains 10 to 15 mg iron/day
RichLiver, Egg yolk, Oyster, Dry fruits, Wheat germs, yeast
MediumMeat, Chicken, Fish, Spinach, Banana, Apple
PoorMilk and its products, Root vagetables
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 17
IRON ABSORPTION
The average daily diet contain 10-15 mg of iron.5% to 10% absorbs dietary iron = 0.5 to 1 mg/dayAdequate for male and postmenopausal
Menstruating/pregnant woman require 1 to 3 mg/dayMenstrual loss is 30 mg/period.
Absorption occurs all over the intestine, but
magnify in the upper part.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 18
To absorb- iron
Ferric to ferrous by acid reducing agent.From gut to Intestinal mucosal cells by1. Divalent metal transporter.From mucosa to plasma by 2. Ferroportin transporter
Absorbed ferrous to plasma by F transporter or oxidised to ferric form and ferric form +apoferritin= ferritin is stored in the mucosal cells.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 19
GUT
Ferric
Ferrous
MUCOSAL CELLS PLASMA
Divalent metal transporter 1 Ferroportin
Ferrous– Ferric + Apoferritin – Ferritin
FerrousFerrous
Ferric
Transferrin+
Circulate in the plasma
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 20
Plasma Cells
Ferric + Transferrin
Released iron
Membrane+ Transferrin Receptors
Endocytosis
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 21
STORAGE
RE cellsLiver, Spleen, Bone-marrow, hepatocytes, myocytesas ferritin and haemosiderin
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 22
Plasma Iron from Old RBC 120 daysIron StoreIntestinal absorption
An Iron common pool
Erythrpoiesis, Other cells, Restorage
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 23
Iron Excertion:-
Iron is tenaciously conserved by the body. Daily excretion in adult male is 0.5 – 1mg.Mainly as exfoliated G.I mucosal cell, some RBC in bile.Other routes are desquamated skin, sweat and urine.In menstruating women, monthly menstrual loss may be averaged to 0.5 – 1 mg/day
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 24
24
Causes of Iron Deficiency Anaemia
• Bleeding
– heavy menstruation– gastric (PU, cancer – occult bleeding) or piles– hookworm infestation – use of NSAIDs for pain /
inflammation
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 25
25
• Increased Physiological Demand for Iron
– Pregnancy and Lactation
– Infancy, children and adolescents (rapid growth)
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 26
26
• Inadequate Absorption – post-gastrectomy – generalized malabsorption
(severe small bowel disease, Crohn’s disease / celiac disease)
• Inadequate Intake –
-- Rare for adult, but extreme poverty
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 27
TY CSU IMU
Normal blood film Severe iron deficiency anaemia
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 28
28
Blood reports
• Hb is low
• MCV is low ( <80fL) – microcytes
• MCHC is low – hypochromic
• Ferritin is low
• Total iron binding capacity (TIBC) is increased
• Serum iron is low
• Transferrin saturation is < 19%
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 29
Indications for Iron therapy
Used for therapy and prophylaxis
1. Iron deficiency anaemia due to dietary lack or to chronic blood loss2. Pregnancy total 1000 mg(50 to 100mg elemental iron = 200 to 500 ug folic acid)3. Absorption is reduced. Mal absorption syndrome.4. Premature babies5. Severe pernicious anaemia with hydroxycobalamine6. 3.As an Astringent:- Ferric chloride is used in throat paint.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 30
Excess Iron Required
1. In pregnancyExpansion of RBC massFoetusLoss during delivery
2. Lactating mother
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 31
Preparation and Doses
1. The preferred type of iron is ferrous salts. Ferrous form is inexpensive, high iron content and are better absorbed than ferric salts.
Sustained release preparations are more expensive but used for patient who cannot tolerate the standard forms.
The preferred route is the Oral Route.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 32
2. Liquid formulation stain teeth. Less satisfactory.
200 mg elemental iron daily in 3 divided doses gives maximum haemopoietic response.Infant and children 3 to 5 mg/kg
30 mg/day is for prophylaxsisAbsorption is better taken in empty stomach. May have side-effects more.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 33
Adverse Effect:- Oral Route
Are common at the therapeutic level.Related to elemental iron dose.Mainly Gastrointestinal symptomsConstipation are common.Blackens the face
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 34
Preparations & Doses 100 to 200 mg elemental iron/dayOral Route
1-Ferrous sulphate dried-200_300mg daily(60 to 100 mg Eiron)2-Ferrous gluconate – 1.2-1.8 g in divided daily doses(140 mg E iron)3. Ferrous Fumerate – 200 – 400 mg is divided daily dose.(140 mg E iron)4. Ferrous succinate and Ferrous glycine sulphate5. Colloidal ferric hydroxide – 200 – 400 mg daily
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 35
Parental Iron Therapy
IndicationsNot tolerated.Failure to absorb.No- complianceIn presence of severe deficiencyAlong with erythropoietin
Total Iron requirement = 4.4 x body wt kg x Hb deficit g/dl
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 36
Parental Iron Therapy
1. Iron dextran injection : Dose 1 ml 2. Iron sorbitol injection : 50 mg of iron/ml
Dose 1.5 mg of iron / kg
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 37
Adverse Effect:-
Local -* Pain at site of in injection. * Pigmentation of skin * Sterile abscess
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 38
Systemic –
* Fever, headache, joint pains, flushing, palpitation, chest pain, dyspnoea, lymph node enlargement * A metallic taste in mouth lasting for few hrs.* An anaphylactoid reaction resulting in vascular collapse & death.* Iron sorbital causes more immediate reaction than iron dextran, should be avoided in patients with kidney disease
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 39
ACUTE IRON POISIONING
High doses of iron salts by mouth can cause severe GI irritation and necrosis of mucous membrane. It occurs mostly in infants& children. It is very rare in adults.Manifestation are vomiting, abdominal pain, haematemesis, diarrhoea, lethargy, cyanosis,dehydration, acidosis, convulsions & finally shock , cardiovascular collapse & death.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 40
TREATMENT:-
1. Chelate iron in the blood, stomach and intestine.2. To prevent further absorption of iron from gut.
A. Desferrioxamine 1 to 2 G I/M give urgently
B. Induce vomiting or perform gastric lavage with sodium bicarbonate solution to render iron insoluble.
C. Give egg yolk & milk orally compete iron.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 41
D. Deferrioxamine 5-10 mg in 100 ml saline may be left in the stomach after lavage to prevent further iron absorption.
E. IV infusion desferrioxamine 80 mg/kg/24h or IM 2 g in sterile water every 12 hourly.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 42
TY CSU IMU
Vitamin B12(Cyanocobalamine)
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 43
Vitamin B12(Cyanocobalamine)
Cobalamins - Active cellular co enzyme.Necessary for DNA synthesis. Formed from Cyanocobalamin and hydroxocobalamin.
Vitamin B12(Cyanocobalamine) is Extrinsic factor in the food. Principal sources - Meat (particularly liver), eggs and dairy products.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 44
Absorption
Vitamin B12 absorption needs Intrinsic factor, glycoprotein secreted by parietal cells in the stomach, binds to vitamin B12 in the duodenum. This vitamin B12–intrinsic factor complex subsequently aids in the absorption of vitamin B12 in the terminal ileum. Then transported bound to plasma glycoprotein - transcobalamin II.
Excess B12 is stored in the liver (80%) and the rest in the kidney, adrenal, pancreas and other organs.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 45
Vit B12 and folic acid are essential vitamins for normal DNA synthesis
Deficiency leads to impaired DNA synthesis; reduced cell division, but RNA and protein synthesis continue large (macrocytic) and fragile RBCs.
Daily requirement- 2.4 ug. 2.6 ug for pregnant mother
Average adult stores ~ 3000 - 5000g
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 46
Red cells – Macrocytosis
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 47
TY CSU IMU
White cells - Hypersegmented neutrophils
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 48
48
Causes of B12 deficiency
• Partial or total gastrectomy• Diseases of distal ileum• Nutritional deficiency: very rare but possible
in strict vegetarians after many years without meat, egg or dairy products
• Fish tapeworm (sequestration of B12 by the worms)
• Prolonged exposure to N2O anaesthesia (N2O inactivates the vitamin)
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 49
Therapy
• Since almost all cases of B12 deficiency are due to malabsorption, parenteral treatment is needed, and for life.
• Hydroxycobalamin (produces higher and more sustained blood level) or cyanocobalamin.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 50
50
Toxicity
• Vit. B12 and folic acid have no known toxic effects even in high doses which are excreted in the urine and faeces
• Rare (allergic) effects: itching, fever, nausea, dizziness, anaphylaxis (especially hydroxycobalamin)
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 51
Folic acid (Pteroyl glutamic acid)
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 52
Folic acid (Pteroyl glutamic acid)
Folates are co-factors in the synthesis of purines and pyrimidines which are essential for DNA synthesis
To be effective folates must be in the tetrahydro (FH4) form. The enzyme dihydrofolate reductase reduces dietary folic acid to FH4 (tetrahydrofolate)
Folates are found in the green vegetables (heat labile), liver (more heat stable), yeast, nuts, cereals, fruits
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 53
• Folic acid is readily and completely absorbed in the duodenum and proximal jejunum
• Is subsequently transported into the blood stream by active and passive transport.
• Since body stores are relatively low and daily requirement high, deficiency (and anaemia) can occur within 1-6 months
• Excreted in urine and stool and destroyed by catabolism
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 54
• The average daily diet contains 500 -700g of folate of which 50 - 200g is absorbed.
• Daily requirement 400 ug. per day• Pregnancy- 600 to 800 ug. per day
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 55
55
Causes of folate deficiency
• Often by dietary insufficiency (poverty, elderly)
• For alcoholics and liver disease, poor diet and very low liver storage
• Pregnancy (deficiency associated with neural tube defect)
• Haemolytic anaemia• Dialysis Patients
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 56
56
•Mal- absorption (e.g. coeliac disease or tropical sprue)
•Drugs that interfere with folate absorption e.g. Phenytoin, Oral contraceptives and Isoniazid
•Methotrexate, Pyrimethamine, Trimethoprim can interfere with metabolism
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 57
57
Therapy
• Parenteral administration is rarely needed because folic acid is well absorbed even in mal-absorption syndromes
• Don’t use in undiagnosed megaloblastic anaemia.
• 600 to 800 micrograms of folate for pregnant mothers
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 58
ERYTHROPOINTIN
In 1906, Paul Carnot, a professor of medicine in Paris, France, and his assistant, DeFlandres, proposed the idea that hormones regulate the production of red blood cells.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 59
Erythropoietin is produced in the kidney and liver, and is involved in the production and differentiation of erythrocytes.
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 60
Erythropoietin
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 61
61
Clinical use
• Anaemia of chronic renal failure(epoietin is given i.v., s.c., or i.p.)
• Anaemia in AIDS patients• Cancer (chemotherapy) related anaemia• Surgery and autologous blood transfusion
(orthopaemic, cardiac procedures)• Myelodysplasia
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 62
Abuse: sportsman to enhance performance
Side effects:
– Flu-like symptoms, – Hypertension, – Encephalopathy with headache, – Disorientation convulsion blood viscosity (due to RBC mass)
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 63
Colony Stimulating Factors (CSF)
Cytokinase stimulate growth, differentiation and functional activitty of colonies of myeloid cells
Some have been developed for clinical use.
FilgrastimLenograstimMolgramostim
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 64
64
G-CSF – Filgrastim (NEUPOGEM)
• Recombinant human G-CSF
• Produced in E.coli
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 65
65
Clinical Uses
• severe neutropenia after autologous hematopoietic stem cell transplantation and high-dose cancer chemotherapy
• reduces morbidity secondary to bacterial and fungal infections
• neutropenia of AIDS patients receiving zidovudine
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 66
66
• Filgrastim is administered by subcutaneous injection or intravenous infusion over at least 30 minutes
• half-life of 3.5 hours
Adverse reactions • mild to moderate bone pain• skin reactions following subcutaneous injection• rare cutaneous necrotizing vasculitis
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 67
67
Lesson Outcomes
1. Discuss the iron metabolism and pharmacokinetics of iron
2. Explain the indications of use for different types of iron preparation in the treatment of iron deficiency anaemia
3. Discuss different types of iron therapy, indications & adverse effects (contraindications)
4. Discuss the iron toxicity & its treatment5. Discuss the pharmacokinetics, indications of use,
therapy and adverse effects for Vitamin B12 & Folic acid
6. Describe the outline of erythropoietin & G-CSF therapy
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 68
68
Contents
• Treatment of Iron deficiency (oral and parental preparations of iron)
• Management of iron overload • Treatment of B12 deficiency (oral and parental
preparations of B12) • Treatment of Folic acid deficiency• Erythropoietin & G-CSF therapy
Operational Obstetrics & Gynecology · Bureau of Medicine and Surgery · 2000 Slide 69
THANK YOU
TY CS & SC IMU